Thanks to the editors at Nature Portfolio #NatureBiotechnology for highlighting Unnatural Products Inc. and the work we're doing in the oral macrocyclic peptide space and Michael Eisenstein for the great write up! https://lnkd.in/gh4kBq4X
Unnatural Products Inc.
Biotechnology
Santa Cruz, CA 5,642 followers
Drugging the undruggable.
About us
Unlocking the potential of macrocycle drug discovery through machine learning and massively parallel synthesis
- Website
-
http://www.unp.xyz
External link for Unnatural Products Inc.
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Santa Cruz, CA
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
Get directions
2161 Delaware Ave
Suite A
Santa Cruz, CA 95060, US
Employees at Unnatural Products Inc.
Updates
-
Unnatural Products Inc. reposted this
Very excited today to announce our research collaboration with Merck to access the Unnatural Products Inc. platform! “This collaboration with Merck leverages macrocycles against one of the most challenging oncology targets and is a testament to the progress we have made in intracellular targeting and the importance of finding new ways to tackle the high-hanging fruit in oncology,” said Cameron Pye, CEO and Co-Founder. “We look forward to working with the Unnatural Products team to develop candidates towards this challenging oncology target.” said Rob Garbaccio, vice president and head, discovery chemistry, Merck Research Laboratories Read the press release here: https://lnkd.in/gHf-CSU9
Unnatural Products, Inc. Enters Research Collaboration with Merck
globenewswire.com
-
Thanks James Waldron & Fierce Biotech for the write up on our research collaboration with Merck announced today. Looking forward to working with such a great partner and what we can accomplish together! Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’ https://lnkd.in/gbarmU4K
Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
fiercebiotech.com
-
Very excited today to announce our research collaboration with Merck to access the Unnatural Products Inc. platform! “This collaboration with Merck leverages macrocycles against one of the most challenging oncology targets and is a testament to the progress we have made in intracellular targeting and the importance of finding new ways to tackle the high-hanging fruit in oncology,” said Cameron Pye, CEO and Co-Founder. “We look forward to working with the Unnatural Products team to develop candidates towards this challenging oncology target.” said Rob Garbaccio, vice president and head, discovery chemistry, Merck Research Laboratories Read the press release here: https://lnkd.in/gHf-CSU9
Unnatural Products, Inc. Enters Research Collaboration with Merck
globenewswire.com
-
Very excited to announce Unnatural Products Inc. $32M Series A raise led by Prem Tumkosit at Merck Global Health Innovation Fund LLC and Vasudev Bailey at ARTIS Ventures to support UNP's mission to drug the undruggable and provide best in class treatments for patients using our macrocycle platform. We're joined by some fantastic new backers on this round and are looking forward to making a real impact in 2024 - more to come! https://lnkd.in/gkvrD2Pj Haitao Zhu First Spark Ventures Nirmesh Patel The Venture Collective (TVC) Vlad Cernouţan LongeVC Elliot Hershberg Not Boring Aneil Mallavarapu Modi Ventures Asset Management Ventures Abstract Ventures Better Ventures Blue Bear Ventures Rising Tide Fund Gaingels Wing Venture Capital
Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innovation Fund and ARTIS Ventures
globenewswire.com